Patents by Inventor Elisabeth Blom

Elisabeth Blom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8846001
    Abstract: The present invention provides radioactive gallium complexes which comprise DOTA-biotin conjugates, incorporating a linker group. Also described are radiopharmaceutical compositions, and methods and uses of the complexes for in vivo imaging involving pre-targeting with avidin.
    Type: Grant
    Filed: September 16, 2010
    Date of Patent: September 30, 2014
    Assignees: GE Healthcare Limited, Hammersmith Imanet Limited
    Inventors: Irina Velikyan, Elisabeth Blom, Bengt Langstrom
  • Publication number: 20120177569
    Abstract: The present invention provides radioactive gallium complexes which comprise DOTA-biotin conjugates, incorporating a linker group. Also described are radiopharmaceutical compositions, and methods and uses of the complexes for in vivo imaging involving pre-targeting with avidin.
    Type: Application
    Filed: September 16, 2010
    Publication date: July 12, 2012
    Applicants: HAMMERSMITH IMANET LMITED, GE HEALTHCARE LIMITED
    Inventors: Irina Velikyan, Elisabeth Blom, Bengt Langstrom
  • Patent number: 8071785
    Abstract: Radioactively labeled derivatives of (R)-3-(1-phenylethyl)-3H-imidazole-4-carboxylic acid esters and one-step methods for preparing these compounds are provided. The radioactively labelled compounds, and pharmaceutical acceptable salts and solvates are useful as radiopharmaceuticals, especially for use in Positron Emission Tomography (PET) for the diagnosis of adrenal cortical masses such as incidentaloma, adenoma, primary and metastatic cortical carcinoma. Associated kits and method for PET studies are also provided.
    Type: Grant
    Filed: June 7, 2007
    Date of Patent: December 6, 2011
    Assignee: GE Healthcare Limited
    Inventors: Bengt Langstrom, Farhad Karimi, Elisabeth Blom, Maria Erlandsson
  • Publication number: 20100150835
    Abstract: The present invention discloses the reactivity of ponytail (“PT”) sulfonates as leaving groups in nucleophilic fluorination reactions. The results showed that using a pentafluorobenzenesulfonate precursor is a suitable leaving group for n. c. a. nucleophilic 18F-fluorination in synthesis of [18F]fluoromethyl benzene, wherein this is a suitable leaving group for 18F-labeling with moderate reactivity. The PT-precursor seems to be quite stable. In an attempt to purify the crude 18F-labeled product using fluorous solid phase extraction (F-SPE), the radio labeled impurities decreased significantly. This provides an opportunity for utilizing PT methodology in both simple and fast purification methods.
    Type: Application
    Filed: February 26, 2008
    Publication date: June 17, 2010
    Inventors: Bengt Langstrom, Farhad Karimi, Elisabeth Blom
  • Publication number: 20090297447
    Abstract: Radioactively labeled derivatives of (R)-3-(1-phenylethyl)-3H-imidazole-4-carboxylic acid esters and one-step methods for preparing these compounds are provided. The radioactively labelled compounds, and pharmaceutical acceptable salts and solvates are useful as radiopharmaceuticals, especially for use in Positron Emission Tomography (PET) for the diagnosis of adrenal cortical masses such as incidentaloma, adenoma, primary and metastatic cortical carcinoma. Associated kits and method for PET studies are also provided.
    Type: Application
    Filed: June 7, 2007
    Publication date: December 3, 2009
    Inventors: Bengt Langstrom, Farhad Karimi, Elisabeth Blom, Maria Erlandsson